SB-4 — Class III drug recall D-0722-2022
Terminated recall by Olympia Compounding Pharmacy dba Olympia Pharmacy, reported 2022-03-30, distributed nationwide. Sub Potent
| Recall number | D-0722-2022 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Olympia Compounding Pharmacy dba Olympia Pharmacy, Orlando, FL, United States |
| Recall initiated | 2022-03-08 |
| Classified | 2022-03-29 |
| Reported by FDA | 2022-03-30 |
| Terminated | 2023-10-04 |
| Distributed | Nationwide (US) |
| Quantity | 1,032 vials |
| NDC | 73198-0023-05, 73198-0023-10 |
| Expiration dates | 2022-05-18 |
Product
SB-4, Papaverine 30mg/mL, Phentolamine 3mg/mL, Alprostadil 40mcg/mL, packaged in a) 5 mL Multi-dose vial NDC 73198-0023-05; b) 10 mL Multi-dose vial NDC 73198-0023-10, Each ML contains: 0.5% Chlorobutanol NF, 0.0005% Edetate Disodium Dihydrate USP, 1.84% Benzyl Alcohol NF, 5% Mannitol USP, 1% Sodium Metabisulfite NF, 2% Ethyl Alcohol USP, Sterile Water for Injection USP, Rx Only, Olympia Pharmaceuticals, Conroy Rd., Ste. 155, Orlando, FL 32835
Reason for recall
Sub Potent
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0722-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.